Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Cancer. 2012 Mar 1;118(5):1404-11. doi: 10.1002/cncr.26363. Epub 2011 Jul 28.
Although surgery offers the greatest chance of a cure for patients with early stage nonsmall cell lung cancer (NSCLC), older and sicker patients often fail to undergo resection. The benefits of surgery in older patients and patients with multiple comorbidities are uncertain.
The authors identified a national cohort of 17,638 Medicare beneficiaries aged ≥66 years living in Surveillance, Epidemiology, and End Results (SEER) areas who were diagnosed with stage I or II NSCLC during 2001 to 2005. Areas with high and low rates of curative surgery for early stage lung cancer were compared to estimate the effectiveness of surgery in older and sicker patients. Logistic regression models were used to assess mortality according to the quintile of area-level surgery rates, adjusting for potential confounders.
Less than 63% of patients underwent surgery in low-surgery areas, whereas >79% underwent surgery in high-surgery areas. High-surgery areas operated on more patients of advanced age and patients with chronic obstructive pulmonary disease than low-surgery areas. The adjusted all-cause 1 year mortality was 18% in high-surgery areas versus 22.8% in low-surgery areas (adjusted odds ratio [OR], 0.89; 95% confidence interval [CI], 0.86-0.93) for each 10% increase in the surgery rate).The 1-year lung-cancer-specific mortality similarly was lower in high-surgery areas (12%) versus low-surgery areas (16.9%; adjusted OR, 0.86; 95% CI, 0.82-0.91) for each 10% increase in the surgery rate.
Higher rates of surgery for stage I/II NSCLC were associated with improved survival, even when older patients and sicker patients underwent resection. The authors concluded that more work is needed to identify and reduce barriers to surgery for early stage NSCLC.
尽管手术为早期非小细胞肺癌(NSCLC)患者提供了最大的治愈机会,但许多年老体弱的患者往往无法接受手术切除。对于老年患者和合并多种合并症的患者,手术的获益尚不确定。
作者从监测、流行病学和最终结果(SEER)地区的 17638 名年龄≥66 岁的 Medicare 受益人群中确定了一个队列,这些患者在 2001 年至 2005 年间被诊断患有 I 期或 II 期 NSCLC。对早期肺癌根治性手术率较高和较低的地区进行比较,以评估手术对年老体弱患者的疗效。采用逻辑回归模型,根据地区手术率五分位数评估死亡率,调整潜在混杂因素。
低手术率地区接受手术的患者不足 63%,而高手术率地区则超过 79%。与低手术率地区相比,高手术率地区接受手术的高龄患者和慢性阻塞性肺疾病患者更多。调整后的全因 1 年死亡率在高手术率地区为 18%,而在低手术率地区为 22.8%(调整后的比值比[OR]为 0.89;95%置信区间[CI]为 0.86-0.93),手术率每增加 10%,全因死亡率相应降低 11%。高手术率地区的 1 年肺癌特异性死亡率也较低(12%对低手术率地区的 16.9%;调整后的 OR 为 0.86;95%CI 为 0.82-0.91),手术率每增加 10%,肺癌特异性死亡率相应降低 11%。
更高的 I/II 期 NSCLC 手术率与生存改善相关,即使对老年患者和合并症较多的患者进行手术。作者认为,需要进一步努力,确定并减少早期 NSCLC 手术的障碍。